Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine
Eye Infections, Bacterial
About this trial
This is an interventional treatment trial for Eye Infections, Bacterial
Eligibility Criteria
Inclusion criteria:
Treatment Naïve patients:
- Any patient who is able to give consent for the study and did not receive an intravitreal injection in the past 6 months
Patients receiving injections:
- Patient currently undergoing treatment for which he/she receives a intravitreal injection in one eye.
Exclusion Criteria:
Treatment Naïve patients:
- Intravitreal injections in the past 6 months
- Use of eye drops for treatment of glaucoma in the past 6 months
- Use of eye drops with antibiotics or steroids in the past 6 months
Patients receiving injections:
- Patient receiving injections in both eyes
- Use of eye drops for treatment of glaucoma in the past 6 months
- Use of eye drops with antibiotics or steroids in the past 6 months
- Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements.
For both groups:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
Sites / Locations
- Bascom Palmer Eye InstituteRecruiting
- Medical Center Ophthalmology AssociatesRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Treatment naïve participants First Group L
Treatment naïve participants Second Group R
Participants undergoing intravitreal injection First Group L
Participants undergoing intravitreal injection Second Group R
Treatment naïve participants randomized to receive Betadine on the left eye and Avenova on the right Eye
Treatment naïve participants randomized to receive Avenova on the left eye and Betadine on the right Eye
Participants undergoing intravitreal injection will receive betadine in the eye that is receiving injections and Avenova in the other eye. Group L are patients that are having intravitreal injections and will receive betadine in the left eye and Avenova in the right eye.
Participants undergoing intravitreal injection will receive betadine in the eye that is receiving injections and Avenova in the other eye. Group R are patients that are having intravitreal injections and will receive betadine in the right eye and Avenova in the left eye.